Chiesi USA, Inc.
1
Recalls
0
Units Recalled
0
Injuries
0
Deaths
Categories: Drug
2026-04-01 to 2026-04-01
| Date | Source | Product | Brand | Severity | Units |
|---|---|---|---|---|---|
| 2026-04-01 | FDA Drug | FDA Recall: CUROSURF (poractant alfa), 240 mg, Intratracheal Suspension, 3L Single-dose-Vial, Rx only, Chiesi US | Chiesi USA, Inc. | Class II | N/A |